We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$7.23M
Cap. Flow
+$41.2M
Cap. Flow %
4.08%
Top 10 Hldgs %
71.39%
Holding
55
New
11
Increased
7
Reduced
25
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 22.55%
2 Healthcare 15.88%
3 Communication Services 13.42%
4 Consumer Staples 9.62%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
26
Barrick Mining
B
$61.5B
$6.48M 0.64%
158,741
-6,115
-4% -$282K
RAMP icon
27
LiveRamp
RAMP
$2.3B
$5.92M 0.59%
223,215
-8,779
-4% -$230K
PCTY icon
28
Paylocity
PCTY
$7.38B
$3.96M 0.39%
+36,611
New +$4.49M
TPB icon
29
Turning Point Brands
TPB
$1.45B
$3.72M 0.37%
42,859
+18,487
+76% +$2.06M
MDLZ icon
30
Mondelez International
MDLZ
$79.5B
$3.23M 0.32%
55,974
-8,573
-13% -$496K
SBH icon
31
Sally Beauty Holdings
SBH
$1.43B
$3.06M 0.3%
220,737
-516,513
-70% -$7.88M
BBWI icon
32
Bath & Body Works
BBWI
$4.06B
$2.9M 0.29%
155,508
-99,103
-39% -$2.14M
BF.A icon
33
Brown-Forman Class A
BF.A
$13.4B
$2.69M 0.27%
+100,354
New +$2.73M
JRVR icon
34
James River Group Holdings
JRVR
$208M
$2.14M 0.21%
338,961
+215,386
+174% +$1.42M
RSKD icon
35
Riskified
RSKD
$694M
$1.91M 0.19%
488,481
-25,195
-5% -$112K
NICE icon
36
Nice
NICE
$5.79B
$1.88M 0.19%
17,091
-3,231
-16% -$369K
IWO icon
37
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
$1.38M 0.14%
+4,400
New +$1.46M
OLED icon
38
Universal Display
OLED
$3.68B
$1.02M 0.1%
11,121
-532
-5% -$58.8K
VRSK icon
39
Verisk Analytics
VRSK
$25.4B
$551K 0.05%
+2,902
New +$589K
ENVX icon
40
Enovix
ENVX
$892M
$59.8K 0.01%
11,550
ALEC icon
41
Alector
ALEC
$168M
$41.5K ﹤0.01%
19,282
CHRS icon
42
Coherus Oncology
CHRS
$217M
$32.6K ﹤0.01%
19,282
CRBU icon
43
Caribou Biosciences
CRBU
$145M
$29.7K ﹤0.01%
15,627
FATE icon
44
Fate Therapeutics
FATE
$286M
$27.4K ﹤0.01%
22,853
CCCC icon
45
C4 Therapeutics
CCCC
$385M
$26.4K ﹤0.01%
10,033
PLRX icon
46
Pliant Therapeutics
PLRX
$64.4M
$23.5K ﹤0.01%
18,613
IVVD icon
47
Invivyd
IVVD
$158M
$14.3K ﹤0.01%
11,012
MIST icon
48
Milestone Pharmaceuticals
MIST
$138M
$12.4K ﹤0.01%
10,414
RANI icon
49
Rani Therapeutics
RANI
$87M
$10.9K ﹤0.01%
14,868
GUTS icon
50
Fractyl Health
GUTS
$109M
$7.74K ﹤0.01%
16,905

Similar funds

Bronte Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Bronte Capital Management held 55 positions worth $1.01B, up 0.72% from $1B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bronte Capital Management deployed $41.2M of net new capital in Q1 2026, opening 11 new positions and adding to 7 existing holdings. Its largest new stake was Walt Disney: 185,677 shares worth $17.9M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Interactive Brokers, an estimated $14.6M trimmed.

  • Bronte Capital Management's largest Q1 2026 buy was Walt Disney: 185,677 shares worth $17.9M.
  • Bronte Capital Management added most to BBB Foods in Q1 2026, an estimated $3.27M increase.
  • Bronte Capital Management's biggest Q1 2026 reduction was Interactive Brokers, cutting an estimated $14.6M.
  • Bronte Capital Management fully exited Fair Isaac in Q1 2026, selling an estimated $2.65M.
  • Bronte Capital Management's ten largest holdings make up 71% of its $1.01B portfolio in Q1 2026.
  • Bronte Capital Management opened 11 new positions and closed 1 in Q1 2026.
  • Bronte Capital Management's portfolio value rose 0.72% quarter-over-quarter to $1.01B.

Based on Bronte Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.